Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Archimedes developed the "Archimedes Model," a sophisticated computer simulation platform used by pharmaceutical companies, payers, researchers, and regulators to simulate clinical trials and predict long-term health outcomes. It has been validated against real-world data such as the SCOUT trial on obesity/cardiovascular risk. The company collaborated with FDA on virtual patient simulations to assess weight loss medications' risks/benefits. Acquired by Kaiser Permanente; continues operations as an internal unit focused on biosimulation/analytics. No direct therapeutic products or clinical results since it is not a drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Archimedes Research.